rs2270359

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000834.5(GRIN2B):​c.2359+451T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.501 in 152,034 control chromosomes in the GnomAD database, including 19,339 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.50 ( 19339 hom., cov: 33)

Consequence

GRIN2B
NM_000834.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0420

Publications

7 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.537 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000834.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
NM_000834.5
MANE Select
c.2359+451T>G
intron
N/ANP_000825.2
GRIN2B
NM_001413992.1
c.2359+451T>G
intron
N/ANP_001400921.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
ENST00000609686.4
TSL:1 MANE Select
c.2359+451T>G
intron
N/AENSP00000477455.1
GRIN2B
ENST00000630791.3
TSL:5
c.2359+451T>G
intron
N/AENSP00000486677.3
GRIN2B
ENST00000637214.1
TSL:5
c.69+39224T>G
intron
N/AENSP00000489997.1

Frequencies

GnomAD3 genomes
AF:
0.501
AC:
76037
AN:
151914
Hom.:
19307
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.543
Gnomad AMI
AF:
0.491
Gnomad AMR
AF:
0.531
Gnomad ASJ
AF:
0.503
Gnomad EAS
AF:
0.197
Gnomad SAS
AF:
0.440
Gnomad FIN
AF:
0.444
Gnomad MID
AF:
0.598
Gnomad NFE
AF:
0.503
Gnomad OTH
AF:
0.516
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.501
AC:
76123
AN:
152034
Hom.:
19339
Cov.:
33
AF XY:
0.497
AC XY:
36951
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.543
AC:
22516
AN:
41436
American (AMR)
AF:
0.532
AC:
8129
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.503
AC:
1745
AN:
3470
East Asian (EAS)
AF:
0.197
AC:
1017
AN:
5168
South Asian (SAS)
AF:
0.441
AC:
2127
AN:
4828
European-Finnish (FIN)
AF:
0.444
AC:
4686
AN:
10544
Middle Eastern (MID)
AF:
0.616
AC:
181
AN:
294
European-Non Finnish (NFE)
AF:
0.503
AC:
34191
AN:
67986
Other (OTH)
AF:
0.513
AC:
1083
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1988
3976
5965
7953
9941
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
676
1352
2028
2704
3380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.508
Hom.:
30651
Bravo
AF:
0.511
Asia WGS
AF:
0.340
AC:
1185
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
8.5
DANN
Benign
0.83
PhyloP100
0.042
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2270359; hg19: chr12-13722313; API